9 Results for "

prostanoid TP receptor

" in MedChemExpress (MCE) Product Catalog:
Products (9)

9 Results for "prostanoid TP receptor" in MCE Product Catalog:

9
9 Cited Publications
Cat. No.: HY-16963
CAS No.: 439288-66-1
GW627368 (GW627368X) is a novel, potent and selective competitive antagonist of prostanoid EP4 receptor with additional human TP receptor affinity, with pKi values of 7.0 and 6.8 for human prostanoid EP4 and TP receptors respectively .
loading...
    loading...
Cat. No.: HY-108972
CAS No.: 98672-91-4
Purity:  ≥99.0%
Research Areas:  

Metabolic Disease

SQ 29548 is a selective thromboxane-prostanoid (TP) receptor antagonist .
loading...
    loading...
Cat. No.: HY-129851
CAS No.: 2055599-51-2
Purity:  98.58%
Research Areas:  

Cardiovascular Disease

NTP42 is a thromboxane A2 (TXA2) receptor antagonist with an IC50 of 3.278 nM for antagonizing T prostanoid receptor (TP)- mediated [Ca 2+] mobilization following stimulation of cells with the alternative TP agonist U46619 . NTP42 can be used for the treatment of pulmonary arterial hypertension (PAH) .
loading...
    loading...
Cat. No.: HY-150270A
CAS No.: 1239578-80-3
Purity:  99.62%
NP-1815-PX sodium is an orally active dual inhibitor of P2X4 and prostaglandin TP receptors, with an IC50 of 0.26 μM against human P2X4 receptors. NP-1815-PX sodium specifically inhibits ATP-mediated prostaglandin production, TP receptor-induced calcium elevation, and the canonical/non-canonical NLRP3 inflammasome signaling pathway. NP-1815-PX sodium selectively blocks smooth muscle contractions induced by ATP, U46619 (HY-108566) and prostaglandin F2α. NP-1815-PX sodium not only produces anti-allodynic effects in vivo, but also significantly alleviates symptoms of DNBS (HY-W324435)-induced colitis (such as weight loss and tissue damage). NP-1815-PX sodium exerts anti-inflammatory effects by downregulating IL-1β levels and Caspase-1 activity. NP-1815-PX sodium is used in studies related to asthma and inflammatory bowel disease (colitis) .
loading...
    loading...
Cat. No.: HY-176990
CAS No.: 165537-72-4
TP receptor antagonist-3 (compound 51280) is a potent thromboxane A2 prostanoid (TP) receptor with an IC50 of 15.7 nM against Human TP. TP receptor antagonist-3 can be used for alzheimer's disease, cardiovascular and respiratory diseases, and cancer research .
loading...
    loading...
Cat. No.: HY-130304
CAS No.: 27415-25-4
Purity:  ≥99.0%
Synonyms: iPE2-III
Research Areas:  

Cardiovascular Disease

8-Isoprostaglandin E2 (iPE2-III) is a member of the isoprostane class of prostanoids. 8-Isoprostaglandin E2 acts at the receptor for thromboxane A2 (the TP) in vivo to induce vasoconstriction and platelet aggregation. 8-Isoprostaglandin E2 enhances receptor-activated NFkappa B ligand (RANKL)-dependent osteoclastic potential of marrow hematopoietic precursors via the cAMP pathway .
loading...
    loading...
Cat. No.: HY-111304
CAS No.: 848188-18-1
MF266-1 is a selective E prostanoid receptor 1 (EP1) antagonist with an Ki value of 3.8 nM. MF266-1 also has moderate selectivity for thromboxane A2 receptor (TP). MF266-1 is promising for research of arthritis .
loading...
    loading...
Cat. No.: HY-114623
CAS No.: 49852-81-5
Purity:  97.1%
Research Areas:  

Inflammation/Immunology

Prostaglandin D2 methyl ester is a prodrug form of Prostaglandin D2 (HY-101988) that acts as a DP receptor inhibitor. can be used for research on allergic inflammations .
loading...
    loading...
Cat. No.: HY-183037
CAS No.: 1354060-46-0
AGN 225660 is a multi-prostanoid receptor antagonist with human IC50 values of 70, 70, 5, 220 and 180 nM for EP1, EP4, TP, DP1, FP. AGN 225660 inhibits secretion of RANTES, IL-8, MCP-1, IL-12p70, and IL-23. AGN 225660 exhibits good ocular bioavailability and reduces ocular inflammation linked to phacoemulsification surgery and uveitis .
loading...
    loading...